R&D Partner Content 2nd Innovation in Obesity Therapeutics Summit Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly, and Boehringer Ingelheim, as well as innovative biotechs
Partner Content Partner Content Maximising the Therapeutic Potential of Complement Mediation... Capturing the Industry’s Most Exciting Developments in Complement-Based Therapeutics
R&D Partner Content The 18th PFS & Injectable Drug Devices Europe Conference Kickstart 2026 in London to explore advances in drug delivery with the experts.
R&D Partner Content The Antifibrotic Drug Development Summit returns this Novemb... Harness cross-fibrotic insights and make new connections this November in Boston
Partner Content Partner Content 7th Cell Therapy Analytical Development Summit Join us in fast-tracking the next era of safe, potent, and robust cell therapies to market!
Partner Content Partner Content 7th TIL Therapies Summit Driving the Next Generation of TIL Therapies for Solid Tumors
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.